Css LLC Karyopharm Therapeutics Inc. Transaction History

Css LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.08 - $5.82 $30,192 - $43,068	7,400 Added 28.76%	33,128 $181,000
Q2 2022 Aug 15, 2022	BUY	$4.15 - $8.37 $9,545 - $19,251	2,300 Added 9.82%	25,728 $116,000
Q1 2022 May 16, 2022	BUY	$5.91 - $14.38 $138,459 - $336,894	23,428 New	23,428 $173,000
Q2 2021 Aug 16, 2021	SELL	$8.11 - $11.11 $82,129 - $112,510	-10,127 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.85 - $17.69 $99,750 - $179,146	10,127 New	10,127 $106,000
Q3 2020 Nov 16, 2020	SELL	$14.14 - $19.71 $151,693 - $211,448	-10,728 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$16.6 - $25.25 $178,084 - $270,882	10,728 New	10,728 $203,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $53.5M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.